Palazzo Sansedoni F. Gabbrielli D. Balestracci L. Bonelli L. Bonelli Conenna F. Collini G. Guasparri P. Petrioli G. Piccinni O. Redon B. Santi F. Sottili F. Toker L. Vigni

Autor: Catoni, Giuliano

Publikováno v: Archivio Storico Italiano, 2006 Jan 01. 1641 (607), 177-180.

Externí odkaz: https://www.jstor.org/stable/26231217

Agut-Labordère D. et Redon B. (éd.), Les vaisseaux du désert et des steppes : les camélidés dans l’Antiquité

Autor: Nicolas Morand

Publikováno v: Frontière·s, Vol 2

Externí odkaz: https://doaj.org/article/c69e3166f9c2430ab4562abc69023675

Signaling-specific inhibition of the CB 1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials.

Autor: Haney M; Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, NY, USA., Vallée M; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France., Fabre S; Aelis Farma, Bordeaux, France., Collins Reed S; Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, NY, USA., Zanese M; Aelis Farma, Bordeaux, France., Campistron G; Aelis Farma, Bordeaux, France., Arout CA; Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, NY, USA., Foltin RW; Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, NY, USA., Cooper ZD; Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, NY, USA.; University of California, Los Angeles, Los Angeles, CA, USA., Kearney-Ramos T; Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, NY, USA., Metna M; Aelis Farma, Bordeaux, France., Justinova Z; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, MD, USA., Schindler C; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, MD, USA., Hebert-Chatelain E; Department of Biology, University of Moncton, Moncton, NB, Canada., Bellocchio L; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France., Cathala A; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France., Bari A; Aelis Farma, Bordeaux, France., Serrat R; Aelis Farma, Bordeaux, France., Finlay DB; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Caraci F; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France.; Department of Drug and Health Sciences, University of Catania, Italy, and Oasi Research Institute-IRCCS, Unit of Translational Neuropharmacology, Troina, Italy., Redon B; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France.; Basic Neuroscience Department, Université de Genève, Genève, Switzerland., Martín-García E; Laboratory of Neuropharmacology, Department of Medicine and Life Sciences, University Pompeu Fabra, Barcelona, Spain., Busquets-Garcia A; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France.; Cell-Type Mechanisms in Normal and Pathological Behavior Research Group, Neuroscience Programme, IMIM Hospital del Mar Medical Research Institute, Barcelona, Spain., Matias I; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France., Levin FR; Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, NY, USA., Felpin FX; Nantes Université, CNRS, CEISAM, UMR 6230, Nantes, France., Simon N; Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Hop Sainte Marguerite, Service de Pharmacologie Clinique, Marseille, France., Cota D; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France., Spampinato U; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France., Maldonado R; Laboratory of Neuropharmacology, Department of Medicine and Life Sciences, University Pompeu Fabra, Barcelona, Spain., Shaham Y; Behavioral Neuroscience Research Branch, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, MD, USA., Glass M; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Thomsen LL; Aelis Farma, Bordeaux, France., Mengel H; Aelis Farma, Bordeaux, France., Marsicano G; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France., Monlezun S; Aelis Farma, Bordeaux, France., Revest JM; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France., Piazza PV; Aelis Farma, Bordeaux, France. pv.piazza@aelisfarma.com.

Publikováno v: Nature medicine [Nat Med] 2023 Jun; Vol. 29 (6), pp. 1487-1499. Date of Electronic Publication: 2023 Jun 08.

Subcellular specificity of cannabinoid effects in striatonigral circuits.

Autor: Soria-Gomez E; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain; Achucarro Basque Center for Neuroscience, Leioa, Spain; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain. Electronic address: edgar.soria@achucarro.org., Pagano Zottola AC; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Mariani Y; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Desprez T; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Barresi M; University of Bordeaux, Bordeaux, France; IMN-UMR CNRS 5293 Neurodegenerative Diseases Institute, Bordeaux, France., Bonilla-Del Río I; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain; Achucarro Basque Center for Neuroscience, Leioa, Spain., Muguruza C; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain., Le Bon-Jego M; University of Bordeaux, Bordeaux, France; IMN-UMR CNRS 5293 Neurodegenerative Diseases Institute, Bordeaux, France., Julio-Kalajzić F; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Flynn R; Department of Cell Biology and Anatomy, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada., Terral G; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Fernández-Moncada I; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Robin LM; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Oliveira da Cruz JF; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Corinti S; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Amer YO; Canada Research Chair in Mitochondrial Signaling and Physiopathology, Department of Biology, University of Moncton, Moncton, NB, Canada., Goncalves J; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Varilh M; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Cannich A; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Redon B; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Zhao Z; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Lesté-Lasserre T; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Vincent P; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Tolentino-Cortes T; Department of Research and Development, IMG Pharma Biotech S.L., Derio, Spain., Busquets-García A; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Puente N; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain; Achucarro Basque Center for Neuroscience, Leioa, Spain., Bains JS; Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada., Hebert-Chatelain E; Canada Research Chair in Mitochondrial Signaling and Physiopathology, Department of Biology, University of Moncton, Moncton, NB, Canada., Barreda-Gómez G; Department of Research and Development, IMG Pharma Biotech S.L., Derio, Spain., Chaouloff F; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France., Lohman AW; Department of Cell Biology and Anatomy, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada., Callado LF; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., Grandes P; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain; Achucarro Basque Center for Neuroscience, Leioa, Spain; Division of Medical Sciences, University of Victoria, Victoria, BC, Canada., Baufreton J; University of Bordeaux, Bordeaux, France; IMN-UMR CNRS 5293 Neurodegenerative Diseases Institute, Bordeaux, France., Marsicano G; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France. Electronic address: giovanni.marsicano@inserm.fr., Bellocchio L; INSERM, U1215 NeuroCentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, France; University of Bordeaux, Bordeaux, France. Electronic address: luigi.bellocchio@inserm.fr.

Publikováno v: Neuron [Neuron] 2021 May 05; Vol. 109 (9), pp. 1513-1526.e11. Date of Electronic Publication: 2021 Mar 25.

Cannabis and exercise: Effects of Δ ⁹ -tetrahydrocannabinol on preference and motivation for wheel-running in mice.

Autor: Hurel I; Endocannabinoids and NeuroAdaptation, NeuroCentre INSERM U1215, 33077 Bordeaux, France; Université de Bordeaux, 33077 Bordeaux, France., Muguruza C; Endocannabinoids and NeuroAdaptation, NeuroCentre INSERM U1215, 33077 Bordeaux, France; Université de Bordeaux, 33077 Bordeaux, France; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain., Redon B; Endocannabinoids and NeuroAdaptation, NeuroCentre INSERM U1215, 33077 Bordeaux, France; Université de Bordeaux, 33077 Bordeaux, France., Marsicano G; Endocannabinoids and NeuroAdaptation, NeuroCentre INSERM U1215, 33077 Bordeaux, France; Université de Bordeaux, 33077 Bordeaux, France., Chaouloff F; Endocannabinoids and NeuroAdaptation, NeuroCentre INSERM U1215, 33077 Bordeaux, France; Université de Bordeaux, 33077 Bordeaux, France. Electronic address: francis.chaouloff@inserm.fr.

Publikováno v: Progress in neuro-psychopharmacology & biological psychiatry [Prog Neuropsychopharmacol Biol Psychiatry] 2021 Mar 08; Vol. 105, pp. 110117. Date of Electronic Publication: 2020 Sep 22.